Oncology News and Research

RSS
Researchers uncover possible targeted therapy for new, high-risk subtype of ALL

Researchers uncover possible targeted therapy for new, high-risk subtype of ALL

New, practical tool may help doctors to easily diagnose cachexia in cancer patients

New, practical tool may help doctors to easily diagnose cachexia in cancer patients

Pancreatic cancer to become third leading cause of death in the EU in 2017

Pancreatic cancer to become third leading cause of death in the EU in 2017

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

FDA approves new combo treatment for patients with advanced sarcomas

FDA approves new combo treatment for patients with advanced sarcomas

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

Researchers to study integration of diabetes, hypertension screening into HIV screening

Researchers to study integration of diabetes, hypertension screening into HIV screening

World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

Researchers describe new method that can reveal distinct invasive properties of cancer cells

Researchers describe new method that can reveal distinct invasive properties of cancer cells

Smoking causes added mutations in DNA of lung cells

Smoking causes added mutations in DNA of lung cells

Rutgers Cancer Institute researcher receives grant to explore cell pathway in triple-negative breast cancer

Rutgers Cancer Institute researcher receives grant to explore cell pathway in triple-negative breast cancer

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Safety of generic oncology drugs in developing countries is uncertain, say researchers

Safety of generic oncology drugs in developing countries is uncertain, say researchers

Researchers find certain short junk DNA play key role in development of Ewing sarcoma

Researchers find certain short junk DNA play key role in development of Ewing sarcoma

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

Study shows only 44% of patients receive accepted, best treatment for cervical cancer

Study shows only 44% of patients receive accepted, best treatment for cervical cancer

Risk and reality do not always match up in prostate cancer biopsies, research suggests

Risk and reality do not always match up in prostate cancer biopsies, research suggests

Simple web-based program may help alleviate mild cognitive problems in cancer survivors

Simple web-based program may help alleviate mild cognitive problems in cancer survivors

Researchers identify potential approach for preventing neurological problems caused by blast-related TBI

Researchers identify potential approach for preventing neurological problems caused by blast-related TBI

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.